Copenhagen, Denmark; October 18, 2005 – Genmab A/S (CSE: GEN) announced today that it has been listed no. 226 amongst the fastest growing European companies included in the 2005 Europe’s 500. The list is an annual ranking of high growth, job creating companies published by Entrepreneurs for Growth and supported by Microsoft and KPMG.

 

“We are delighted to have made the Europe’s 500 list” said Lisa Drakeman, Ph.D., Chief Executive Officer of Genmab. “We believe that Genmab has earned this recognition due to our broad product pipeline and ability to sustain a high level of innovation by entering into strategic partnerships with world renowned pharma and biotech companies.”